Diplomat Pharmacy targets key markets
By HME News Staff
Updated Tue September 19, 2017
FLINT, Mich. - Diplomat Pharmacy has acquired Focus Rx Pharmacy Services, a specialty and infusion pharmacy with two locations in New York state.
“This partnership opens growth opportunities, especially in the key markets of New York and New Jersey,” said Phil Rielly, vice president of Diplomat and president of Diplomat Specialty Infusion Group. “Focus Rx brings over 15 regional and national payer contracts, boosting Diplomat's prescription and payer access.”
Focus Rx provides home infusion and specialty prescription management services. It is expected to generate about $47 million in revenue and $3 million in adjusted EBITDA for the full year 2017.
Last year, Diplomat Pharmacy launched Diplomat Specialty Infusion Group, a brand to unite five subsidiaries: American Homecare Federation, At-Home IV Infusion Professional, BioRx, MedPro Rx and XAS Infusion.
Diplomat's specialty infusion services focus on individuals living with chronic conditions like alpha-1 antitrypsin deficiency, hemophilia, hereditary angioedema, immune deficiencies, nutritional deficiencies and von Willebrand disease.
Comments